Thol et al. further reported a significantly higher rate of relapse within one year, and Shou et al. further showed that SETBP1 mutation is associated with poor prognosis in patients with MDS and CMML [8,44,45,46,47,48,49]. The gene discussed is SETBP1; the disease is myelodysplastic syndrome.